Intravenous iron exposure and mortality in patients on hemodialysis - Wikidata - awgldk - TriplyDB

Intravenous iron exposure and mortality in patients on hemodialysis

Intravenous iron exposure and mortality in patients on hemodialysis

http://www.wikidata.org/entity/Q34455198

about

Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century Safety concerns about intravenous iron therapy in patients with chronic kidney disease Efficiency of Original versus Generic Intravenous Iron Formulations in Patients on Haemodialysis Safety of intravenous iron in hemodialysis patients.Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection.The Labile Side of Iron Supplementation in CKD Target-based Anemia Management with Erythropoiesis Stimulating Agents (Risks and Benefits Relearned) and Iron (Still More to Learn).Overview of iron metabolism in health and disease.Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Balancing Benefits and Safety with Intravenous Iron Treatment.Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model.Intravenous iron exposure and outcomes in patients on hemodialysis.Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions.Estimating Effects of Dynamic Treatment Strategies in Pharmacoepidemiologic Studies with Time-varying Confounding: A Primer.Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis.Medical safety in the care of the person with end-stage kidney disease.Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.Intravenous Irons: From Basic Science to Clinical Practice Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease

P2860

Q26752664-C6C0A55C-F6E9-41ED-B372-20EA018E2CFE Q26764881-37AF5B81-0ABA-4402-B96D-87E5D70208DC Q28547636-48F905B6-4C4E-4B07-948B-ED791B3CCFCA Q30234981-D180C609-DC71-4691-8C41-43AF644C560E Q36123593-D7FAE79A-8B23-4D4B-BAE3-EDA1FB97E49F Q38496987-B0773E8C-AFEF-4CA4-AC44-EC6B3AFC1D8D Q39022863-7B914F29-97E9-4C03-A683-C8633FDAB37E Q39179833-4BF3E693-8C9F-41E7-80E2-A2EE69E94C8A Q40340927-1408AC81-15BF-42F8-9B9D-13ADEFDBB720 Q40526919-1CEC9823-1C35-4F4B-8B77-4AEA464AC134 Q42630143-75BCB581-01AE-4106-9199-EE152019B336 Q42975965-AEF8EEB5-FC99-4A52-89BE-2AC0405FCBBB Q44676908-FDA5E4CA-D89B-4580-A5F2-530C2DB2981B Q47102798-247BFDD4-28D0-4E50-ACC7-068F7D0B3DC9 Q47369859-9BC3809F-5CCD-4EB7-9C58-C014F953AB58 Q47835950-12246232-460D-4A04-975A-B335DC36F82F Q48225857-17750675-8EBE-44D1-A21C-B2EC42DB1C1E Q49791535-5B00EC59-E0EB-40C2-B1CF-4A1AE14D0138 Q50119222-7E4CAD08-FD48-48D5-846B-3B1B9B90DC5B Q52381914-2FB18192-FBE3-4083-B0ED-0209E2114BB9 Q53823548-1E1EC859-6165-4BB4-8F1B-1A2B276A245C Q57167424-52C22B7A-1BCC-439F-8991-F2F9F4A9CACB Q58700150-159014A9-EFED-461E-912B-B31CD8A15BF3

P2860

Intravenous iron exposure and mortality in patients on hemodialysis

http://www.wikidata.org/entity/Q34455198

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intravenous iron exposure and mortality in patients on hemodialysis

@ast

Intravenous iron exposure and mortality in patients on hemodialysis

@en

Intravenous iron exposure and mortality in patients on hemodialysis

@nl

type

label

Intravenous iron exposure and mortality in patients on hemodialysis

@ast

Intravenous iron exposure and mortality in patients on hemodialysis

@en

Intravenous iron exposure and mortality in patients on hemodialysis

@nl

prefLabel

Intravenous iron exposure and mortality in patients on hemodialysis

@ast

Intravenous iron exposure and mortality in patients on hemodialysis

@en

Intravenous iron exposure and mortality in patients on hemodialysis

@nl

P1433

Q34455198-FF36AC14-CCB9-4AA6-82BB-B386FC9295BE

P1476

Q34455198-CFB95242-532E-4E7A-AC5E-95D1FC729731

P2093

Q34455198-0EAC8466-0DAE-41A9-BDE2-41F1A25DF350

Q34455198-546A4BE7-75C3-4428-B452-B02A26915724

Q34455198-5CB0067F-0E5C-4D74-8409-E1D6347C4D86

Q34455198-80A81BFF-9E41-43A6-BA60-E5A212310198

Q34455198-85874B19-6E89-4FAB-A101-46F33DFD59BB

Q34455198-94522A83-058A-4768-890A-67B817B9141B

Q34455198-B46C1A6B-2A35-455C-8D71-F9F251A6CCC1

Q34455198-E19A2919-AC94-485F-B9B0-9636BA4932DD

Q34455198-F29C92EA-F5A9-41B7-A15D-A9DAAD4ACDE2

Q34455198-FB65DD75-5F18-4D62-9D5D-FB4E4E64F1F6

P2860

Q34455198-076176E7-F02A-40D3-A436-CC58BBF11088

Q34455198-10274826-E7AF-423D-9F5C-46A030403F97

Q34455198-147872CF-8D67-4CCB-B00C-D71CF4FBBC65

Q34455198-199C76C1-5728-4F45-B0D6-89D0AF462C14

Q34455198-3A4E0FFC-CB40-477D-B57B-37B39237F62E

Q34455198-4382F697-194E-4B46-A5C2-8937C33EE23D

Q34455198-4BB0232E-25C2-4B28-9086-B0573D87C62D

Q34455198-5A1409B3-99EE-485F-8298-DB3EA33065E0

Q34455198-5E9EF486-856E-4CC8-B19D-715D1BCFF156

Q34455198-654FA36F-A17D-41DD-93D1-D2322A509832

P304

Q34455198-A006BF8E-0EB2-4B8A-A4B2-87542EE77780

P31

Q34455198-A57343CA-75B3-45F3-8CD6-4B8886A95710

P356

Q34455198-70D94ECE-B2F8-420A-A746-C8E7D27A71A1

P433

Q34455198-6BA8D4C2-C39F-4F57-BA3C-E7925926435D

P478

Q34455198-63D26E95-8AA5-48A8-AE26-E3B22957AD54

P50

Q34455198-31C6CB74-4F11-41F9-AF1C-8D8F707C5F83

Q34455198-3B8E2377-DD18-4B53-B4AB-3F32772EF30F

Q34455198-52DDF8A3-84C1-4728-9905-1C6FEDBC3970

Q34455198-573040C7-0E06-40AE-9FE1-385FE4DE31C5

Q34455198-6A08CB90-5523-4F4A-8B85-1995D29835EF

Q34455198-81B4C311-2603-46BB-9097-2008FFF0D7BF

Q34455198-A1C600FE-DC36-446D-AD68-CFDFE03B655C

P577

Q34455198-2B1B74F8-F2C4-421E-85E8-BB7EDF36BE09

P5875

Q34455198-DEDB8EB8-82D0-4690-AFA9-CB992B64B34E

P698

Q34455198-2E9BABA2-C23D-43F5-82F7-EFDDD74BA23C

P921

Q34455198-881946E4-0FBC-4E9B-9856-415AC3D490B2

P932

Q34455198-A9724090-A3C2-4767-92D0-66752302DC71

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Intravenous iron exposure and mortality in patients on hemodialysis

@en

P2093

Aidan McDermott

http://www.w3.org/2001/XMLSchema#string

Albert W Wu

http://www.w3.org/2001/XMLSchema#string

Courtney Cook

http://www.w3.org/2001/XMLSchema#string

Dana C Miskulin

http://www.w3.org/2001/XMLSchema#string

Deidra C Crews

http://www.w3.org/2001/XMLSchema#string

Developing Evidence to Inform ...... al Disease Study Investigators

http://www.w3.org/2001/XMLSchema#string

Jing Zhou

http://www.w3.org/2001/XMLSchema#string

Klemens B Meyer

http://www.w3.org/2001/XMLSchema#string

Patti L Ephraim

http://www.w3.org/2001/XMLSchema#string

Wieneke M Michels

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials

A randomized controlled study of iron supplementation in patients treated with erythropoietin

Marginal structural models and causal inference in epidemiology

Pathobiology of the role of iron in infection.

Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Myoglobin and cytochrome response during repair of iron deficiency in the rat.

Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease

Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.

Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.

P304

1930-1939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03370414

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Bernard G. Jaar

Karen Bandeen-Roche

Stephen M. Sozio

L Ebony Boulware

Julia J Scialla

P577

2014-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266974929

http://www.w3.org/2001/XMLSchema#string

P698

25318751

http://www.w3.org/2001/XMLSchema#string

P921

P932

4220761

http://www.w3.org/2001/XMLSchema#string